Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/174145
Title: Multidisciplinary clinical approach to cancer patients with immune-related adverse events induced by checkpoint inhibitors
Author: Londoño Hurtado, María Carlota
Reig, María
RETOINMUNOMultidisciplinary Group
Keywords: Oncologia
Càncer
Immunoteràpia
Oncology
Cancer
Immunotheraphy
Issue Date: 19-Nov-2020
Publisher: MDPI
Abstract: Immune-oncology is a major breakthrough in cancer treatment and has become the standard of care for a wide variety of solid organ malignancies. Unfortunately, manipulation of the immune system with checkpoint inhibitors may result in an immune-based attack of normal tissues which can lead to treatment discontinuation. These immune-related adverse events (irAEs) are diverse and affect several organs, constituting a new clinical challenge in the management of cancer patients. The complexity of this scenario requires a multidisciplinary approach that allows the early identification, diagnosis and treatment of specific irAE, ruling out other non-related adverse events. Hospital Clinic has a multidisciplinary team seeking to develop a coordinated strategy to facilitate the access of patients with suspected irAEs to specialised care resulting in harmonised management that guarantees the best patient care. The aim of the manuscript was to describe the current evidence on the management of irAEs reflecting a coordinated multidisciplinary approach to face this clinical challenge regardless of the immunotherapy indication.
Note: Reproducció del document publicat a: https://doi.org/10.3390/cancers12113446
It is part of: Cancers, 2020, vol. 12, num. 3446
URI: http://hdl.handle.net/2445/174145
Related resource: https://doi.org/10.3390/cancers12113446
ISSN: 2072-6694
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
705133.pdf1.92 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons